The second day of the J.P. Morgan Healthcare Conference, much like the first, didn’t include the type of market-moving acquisitions or announcements that might break …
In some ways, AstraZeneca’s COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective COVID-19 …
Avacta Group plc (AIM: AVCT), a clinical-stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces …
ECYT lives squarely in small-cap territory. And that’1018s not a bad thing in 2018. On a year-to-date basis, the small-cap focused Russell 2000 Index has …
The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the …
Investors have placed Sino Biopharmaceutical ADR (SBHMY) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward …
